RJA
IVOG icon

Raymond James & Associates’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Raymond James & Associates’s Portfolio IVOG Stock Details IVOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.02M Buy
8,898
+26
+0.3% +$2.89K ﹤0.01% 2677
2024
Q2 		$972K Sell
8,872
-374
-4% -$41.1K ﹤0.01% 2638
2024
Q1 		$1.05M Sell
9,246
-9,215
-50% -$953K ﹤0.01% 2566
2023
Q4 		$1.81M Buy
18,461
+7,483
+68% +$685K ﹤0.01% 2151
2023
Q3 		$991K Sell
10,978
-61
-0.6% -$5.73K ﹤0.01% 2465
2023
Q2 		$1.03M Buy
11,039
+252
+2% +$22.4K ﹤0.01% 2450
2023
Q1 		$958K Buy
10,787
+4,291
+66% +$380K ﹤0.01% 2475
2022
Q4 		$550K Sell
6,496
-310
-5% -$26.6K ﹤0.01% 2836
2022
Q3 		$535K Sell
6,806
-4
-0.1% -$343 ﹤0.01% 2825
2022
Q2 		$538K Sell
6,810
-44
-0.6% -$3.84K ﹤0.01% 2875
2022
Q1 		$659K Sell
6,854
-404
-6% -$38.7K ﹤0.01% 2889
2021
Q4 		$767K Buy
7,258
+210
+3% +$21.9K ﹤0.01% 2796
2021
Q3 		$694K Buy
7,048
+36
+0.5% +$3.63K ﹤0.01% 2826
2021
Q2 		$704K Buy
7,012
+234
+3% +$23.3K ﹤0.01% 2828
2021
Q1 		$659K Buy
6,778
+1,648
+32% +$157K ﹤0.01% 2805
2020
Q4 		$459K Sell
5,130
-744
-13% -$61.7K ﹤0.01% 2872
2020
Q3 		$438K Sell
5,874
-1,068
-15% -$78.9K ﹤0.01% 2726
2020
Q2 		$483K Sell
6,942
-374
-5% -$24.1K ﹤0.01% 2604
2020
Q1 		$404K Sell
7,316
-1,522
-17% -$104K ﹤0.01% 2568
2019
Q4 		$649K Buy
8,838
+712
+9% +$50.8K ﹤0.01% 2546
2019
Q3 		$566K Buy
8,126
+864
+12% +$60.3K ﹤0.01% 2562
2019
Q2 		$509K Buy
7,262
+490
+7% +$33.7K ﹤0.01% 2651
2019
Q1 		$459K Sell
6,772
-188
-3% -$12.2K ﹤0.01% 2717
2018
Q4 		$410K Buy
6,960
+200
+3% +$13K ﹤0.01% 2673
2018
Q3 		$489K Buy
6,760
+506
+8% +$36.4K ﹤0.01% 2718
2018
Q2 		$436K Buy
6,254
+80
+1% +$5.53K ﹤0.01% 2773
2018
Q1 		$417K Buy
6,174
+178
+3% +$12.1K ﹤0.01% 2683
2017
Q4 		$399K Buy
5,996
+176
+3% +$11.5K ﹤0.01% 2669
2017
Q3 		$365K Buy
5,820
+1,556
+36% +$94.9K ﹤0.01% 2662
2017
Q2 		$259K Sell
4,264
-2,914
-41% -$175K ﹤0.01% 2822
2017
Q1 		$423K Sell
7,178
-1,148
-14% -$66.7K ﹤0.01% 2489
2016
Q4 		$466K Buy
+8,326
New +$454K ﹤0.01% 2378

Other funds holding IVOG

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
OWA
Octavia Wealth Advisors Cincinnati, Ohio $1.16B AUM 25.42% 1-Year Est. Return
SCM
Stordahl Capital Management Greenwood Village, Colorado $546M AUM 20.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $626M AUM 17.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Raymond James & Associates's IVOG Position: Q3 2024 in Review

Raymond James & Associates increased its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) stake by 0.29% in Q3 2024, buying an estimated $2.89K and bringing the position to 8,898 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

Raymond James & Associates first reported a position in IVOG in Q4 2016 and has held it in 32 quarters since. The position peaked at $1.81M in Q4 2023. 138 funds tracked by Wall St. Rank hold IVOG as of Q3 2024.

  • Raymond James & Associates held 8,898 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $1.02M as of Q3 2024.
  • Raymond James & Associates bought 26 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q3 2024, an estimated $2.89K.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2677 holding.
  • Raymond James & Associates first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2016 and has held it in 32 quarters since.
  • Raymond James & Associates's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $1.81M in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.